Science | ABNewswire

Atomedge Highlights Early Contribution to Groundbreaking AR Anatomy Education Initiative

Atomedge’s advanced 3D Anatomy Model content is designed for integration into next-generation medical education, augmented reality, and immersive learning platforms. Atomedge highlights its early contribution to augmented reality anatomy education and its continued focus on advanced 3D Anatomy Model solutions … Continue reading →

Major Depressive Disorder Treatment Pipeline Shows Strong Momentum as 75+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Major Depressive Disorder Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline landscape. It covers the Major Depressive Disorder pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Sarcopenia Clinical Trial Pipeline Expands as 18+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Sarcopenia Pipeline Insight 2026” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Sarcopenia pipeline landscape. It covers the Sarcopenia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Sarcopenia therapeutics … Continue reading →

Dengue Clinical Trial Pipeline Shows Potential with Active Contributions from 20+ Key Companies | DelveInsight

DelveInsight’s, “Dengue Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Dengue pipeline landscape. It covers the Dengue pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Dengue therapeutics assessment … Continue reading →

Generalized Myasthenia Gravis Clinical Trial Pipeline Accelerates as 10+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Generalized Myasthenia Gravis Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Generalized Myasthenia Gravis (gMG) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Sjögren’s Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Sjogren’s Syndrome Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Sjogren’s Syndrome pipeline landscape. It covers the Sjogren’s Syndrome pipeline drugs profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

International Chemical Industry Fair (ICIF) 2026 Set to Redefine Global Chemical Procurement Behavior at Shanghai New International Expo Centre, September 15-17, 2026

International Chemical Industry Fair — ICIF ICIF 2026, held September 15–17 at SNIEC Shanghai, positions itself as a global hub for petrochemical industry events, chemical raw materials procurement, and digital transformation solutions. Bringing 2,218 exhibitors and 80,000 buyers, the event … Continue reading →

Nori Featured in Google Play Story Just 2 Months After Launch: AI Family Butler Redefines Household Collaboration Efficiency

60 Days Post-Launch, the Emerging App Joins Ranks of Global Benchmark Products, Leveraging AI to Free Families from Time-Consuming Chores New York, US – Nori, a tech company specializing in AI-powered household ecosystems, today announced its flagship product Nori Family … Continue reading →

Non-Alcoholic Fatty Liver Disease Pipeline Shows Strong Momentum as 90+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Non-Alcoholic Fatty Liver Disease Pipeline Insight 2026” report provides comprehensive insights about 90+ companies and 100+ pipeline drugs in Non-Alcoholic Fatty Liver Disease pipeline landscape. It covers the Non Alcoholic Fatty Liver Disease pipeline drug profiles, including clinical and … Continue reading →

Marginal Zone Lymphoma Clinical Trial Pipeline Expands as 50+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Marginal Zone Lymphoma Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Marginal Zone Lymphoma pipeline landscape. It covers the Marginal Zone Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Friday - May 22, 2026

Category Archives: Science